D
SAB Biotherapeutics, Inc. SABS
$2.19 $0.13956.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -94.63% 54.39% -10.10% -41.09% -45.96%
Total Depreciation and Amortization -0.49% -0.94% -18.74% -8.38% -46.83%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 128.03% -250.06% 197.81% 158.46% 65.53%
Change in Net Operating Assets -11.43% 156.49% -189.89% 696.16% 109.49%
Cash from Operations 8.28% 18.20% -51.50% 18.47% 28.21%
Capital Expenditure -- -- 44.77% -91.05% 59.33%
Sale of Property, Plant, and Equipment -100.00% -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 11.29% -50.24% 991.96% -109.34% 136.09%
Cash from Investing 11.28% -49.94% 909.54% -110.27% 135.78%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -1.11% 37.29% 57.77% -157.27% -1.98%
Issuance of Common Stock -- -- -- -- -100.00%
Repurchase of Common Stock 100.00% 91.57% -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 100.00% 63.61% 58.96%
Cash from Financing 0.11% -180.18% 132.19% -110.00% 18.61%
Foreign Exchange rate Adjustments 322.12% 114.72% -707.79% 67.84% 200.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 40.20% -1,092.39% 96.62% -351.58% 107.54%